| HOME >> BIOLOGY >> TECHNOLOGY |
Treasury stock purchases (131.4) (125.0)
Exercise of stock options 24.9 21.1
Excess tax benefits from stock-based
payments 5.5 2.4
Net cash used in financing activities (123.7) (120.0)
Effect of exchange rate changes on cash 8.1 3.7
Net change in cash and cash equivalents 29.0 38.4
Cash and cash equivalents at January 1 173.8 98.6
Cash and cash equivalents at March 31 $202.8 $137.0
SIGMA-ALDRICH CORPORATION
Supplemental Financial Information - (Unaudited)
Sales Growth by Business Unit
Three Months
Ended September 30, 2007
Currency Adjusted
Reported Impact Acquisition (Organic)
Research Essentials 8.6% 4.2% -% 4.4%
Research Specialties 13.6% 4.8% -% 8.8%
Research Biotech 11.2% 4.0% -% 7.2%
SAFC 19.8% 4.0% 9.7% 6.1%
Total 14.0% 4.3% 2.7% 7.0%
Nine Months
Ended September 30, 2007
Currency Adjusted
Reported Impact Acquisition (Organic)
Research Essentials 8.3% 3.9% -% 4.4%
Research Specialties 13.0% 4.4% -% 8.6%
Research Biotech 7.0% 3.6% -% 3.4%
SAFC 20.0% 4.0% 7.5% 8.5%
Total 1
'/>"/>
| SOURCE Sigma-Aldrich Copyright©2007 PR Newswire. All rights reserved |